CVE-2014-6721 describes a critical vulnerability in version 1.2.0 of the Pharmaguideline Android application, where it fails to properly validate X.509 certificates from SSL servers. This oversight enables man-in-the-middle (MitM) attackers to spoof legitimate servers, potentially leading to the compromise of sensitive user information. The vulnerability carries a CVSS score of 5.4, indicating a medium severity, and can be exploited with medium complexity over an adjacent network, resulting in partial confidentiality, integrity, and availability impacts. There is no evidence of active exploitation, publicly available exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
1.2.0CPE matchmatch criteria | cpe:2.3:a:pharmaguideline:pharmaguideline:1.2.0:*:*:*:*:android:*:* |
CVSS version used by this source: 2.0
AV:A/AC:M/Au:N/C:P/I:P/A:P
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.0 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.